Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-08

Clinical Trial Update: Efficacy and Tolerability of Hemopatch After Hepatic Resection [NA]

View source ↗

Summary

Clinical trial update on Hemopatch for hemostasis after liver tumor resection, reporting on efficacy in bleeding control and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemopatch

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Hepatectomy, Cancer, Metastatic | NA | Status: UNKNOWN